Brain imaging and its implications for studying centrally targeted treatments in irritable bowel syndrome: a primer for gastroenterologists.

UNC Center for Functional GI and Motility Disorders, University of North Carolina at Chapel Hill, Room 1110 Bioinformatics Building CB#7080, Chapel Hill, NC 27599-7080, USA.
Gut (Impact Factor: 13.32). 06/2005; 54(5):569-73. DOI: 10.1136/gut.2004.058446
Source: PubMed

ABSTRACT Research into brain-gut interactions, and the use of brain imaging, as potential investigative tools for functional gastrointestinal disorders, such as irritable bowel syndrome, is a promising new area. Studies are beginning to identify the structure and function of regions of the brain and their relationships to pain perception, stress, and other psychosocial variables. These imaging modalities may also have diagnostic potential, and perhaps even therapeutic applications, particularly with regard to understanding the benefit of centrally targeted modalities such as antidepressants and psychological treatments.

Download full-text


Available from: Douglas Drossman, Jul 03, 2015
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Fibromyalgia is a condition which appears to involve disordered central afferent processing. The major symptoms of fibromyalgia include multifocal pain, fatigue, sleep disturbances, and cognitive or memory problems. Other symptoms may include psychological distress, impaired functioning, and sexual dysfunction. The pathophysiology of fibromyalgia remains uncertain but is believed to be largely central in nature. In 1990 the American College of Rheumatology (ACR) published diagnostic research criteria for fibromyalgia. The criteria included a history of chronic and widespread pain and the presence of 11 or more out of 18 tender points. Pain was considered chronic widespread when all of the following are present: pain in the left side of the body; pain in the right side of the body; pain above the waist; pain below the waist. In addition, axial skeletal pain must be present and the duration of pain must be more than 3 months. A tender point is considered positive when pain can be elicited by pressures of 4 kg/cm2 or less. For tender points to be considered positive, the patient must perceive the palpation as painful; tenderness to palpation is not sufficient. However, over the next 20 years it became increasingly appreciated that the focus on tender points was not justified. In 2010 a similar group of investigators performed a multicenter study of 829 previously diagnosed fibromyalgia patients and controls using physician physical and interview examinations, including a widespread pain index (WPI), a measure of the number of painful body regions. Random forest and recursive partitioning analyses were used to guide the development of a case definition of fibromyalgia, to develop new preliminary ACR diagnostic criteria, and to construct a symptom severity (SS) scale. The most important diagnostic variables were WPI and categorical scales for cognitive symptoms, un-refreshed sleep, fatigue, and number of somatic symptoms. The categorical scales were summed to create an SS scale. The investigators combined the SS scale and the WPI to recommend a new case definition of fibromyalgia: (WPI > or = 7 AND SS > or = 5). Although there is no known cure for fibromyalgia, multidisciplinary team efforts using combined treatment approaches, including patient education, aerobic exercise, cognitive behavioral therapy, and pharmacologic therapies (serotonin norepinephrine reuptake inhibitors [e.g., duloxetine, milnacipran] and alpha 2-delta receptor ligands [e.g., pregabalin]) might improve symptoms as well as function in patients with fibromyalgia.
    Pain physician 14(2):E217-45. · 4.77 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Aims of the thesis: The first aim, (Study I) of this thesis was to compare co-morbidity of the reported symptoms and its relation to healthcare seeking behaviour among non-patients who had persistent functional gastro-intestinal disorders (FGID) or who were strictly GI symptom free (SSF). The second aim (study II) was to compare FGID sufferers primary health care consumption, as registered in their medical records. The third aim (study III) was to investigate the occurrence of a history of abuse, and the possible association with consultation rate, and the fourth aim (study IV) was to investigate the possible influence of a negative parental rearing experienced during childhood. Methods: The Abdominal symptom questionnaire (ASQ) was mailed to a random sample of 1537 adults aged 20-87 years from the municipality of Östhammar, Sweden (n= 21,545 in 1995). From the obtained response and by integrating results from previous studies performed in 1988 and 1989, 244 subjects with FGID (e.g. FD and/or IBS) and 219 SSF subjects were invited to their local health centers for completing the ASQ again in addition to a set of other questionnaires. From the results in the ASQ, 141 subjects with persistent FGID and 97 SSF subjects formed the study groups of the studies I,III and IV. A subgroup living in the eastern part of Östhammar constituted the study groups in study II. The used questionnaires were; Complaint score questionnaire (CSQA), Psychological General Well-Being (PGWB), Hospital Anxiety and Depression Scale (HADS), Sexual, physical and emotional abuse (ABQ), Coping strategies questionnaire (CSQ), Social support (ISSI), and the Multidimensional Health locus of control scale (MHLC). Results: In study I: Non-patients with FGID have a higher risk of psychological illness (OR 8.4, CI95: 4.0-17.5) than somatic illness (OR 2.8, CI95: 1.3-5.7) or ache and fatigue symptoms (OR 4.3, CI95:2.1-8.7). Patients with FGID have more severe GI symptoms than healthy controls. In study II: of the FGID patients, 97% had a non-GI diagnosis, compared to 100% of SSF (ns). The mean number of consultations, prescriptions, diagnoses as well as anxiety level and depression were all statistically significantly higher (p<0.05) in FGID compared to SSF, whereas the number of referrals and sick leave were not. Besides a GI diagnosis, there was no significant difference (p>0.05) in the spectrum of morbidity in terms of ICD-9 subgroup classification, except an increased proportion of older SSF subjects with circulatory disorders and hypertension. In study III: Women with FGID had a higher risk of having a history of some kind of abuse, as compared with the SSF controls (45% vs.16%), in contrast to men (29% vs. 24% n.s.). Women with a history of abuse and FGID had reduced HRQoL as compared with women without abuse history. In study IV: Neuroticism and a parental rejective rearing style were identified as risk factors for FGID. FGID consulters reported an increased parental rejection and reduced health-related quality of life. Moreover, consulters had a higher exposure to abuse in childhood, a lower availability of social attachment and less adequacy of social interaction than non-consulters. Conclusions: FGID is related to an increased demand on primary health care due to an increased overall co-morbidity. Women with longstanding FGID often have a history of physical, emotional or sexual abuse which is associated with a poor HRQoL and increased health care seeking. Negative parental upbringing represents an aggravating factor in FGID. The treatment of FGID should involve assessment of psychological distress.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Summary form only given. RESURF LDMOS transistors are utilized in high side driver applications and other applications that mandate electrical isolation between source and substrate by using isolated RESURF technology. However, the BCD process using conventional isolated RESURF LDMOS structures cannot provide high efficiency vertical NPN transistors due to the dependence of the RESURF LDMOS BV<sub>dss</sub> (source to drain breakdown voltage) upon the epi thickness. In this paper, we propose a new isolated RESURF LDMOS. With the use of n-well near the drain region, we can avoid electric field concentration below the drain region. P-well dose, p-well length and extended drain dose should be optimized to reduce surface field of the proposed isolated RESURF LDMOS regardless of epi thickness.
    Device Research Conference, 2002. 60th DRC. Conference Digest; 02/2002